Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial.

Levitsky A, Brismar K, Hafström I, Hambardzumyan K, Lourdudoss C, van Vollenhoven RF, Saevarsdottir S.

RMD Open. 2017 Aug 9;3(2):e000458. doi: 10.1136/rmdopen-2017-000458. eCollection 2017.

2.

Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.

van Wesemael TJ, Ajeganova S, Humphreys J, Terao C, Muhammad A, Symmons DP, MacGregor AJ, Hafström I, Trouw LA, van der Helm-van Mil AH, Huizinga TW, Mimori T, Toes RE, Matsuda F, Svensson B, Verstappen SM, van der Woude D.

Arthritis Res Ther. 2016 Dec 1;18(1):285.

3.

The association between diet and glucocorticoid treatment in patients with SLE.

Lourdudoss C, Hafström I, Frostegård J, van Vollenhoven R.

Lupus Sci Med. 2016 Jan 27;3(1):e000135. doi: 10.1136/lupus-2015-000135. eCollection 2016.

4.

Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study.

Ajeganova S, Gustafsson T, Jogestrand T, Frostegård J, Hafström I.

Arthritis Res Ther. 2015 Mar 25;17:84. doi: 10.1186/s13075-015-0595-4.

5.

Comparing Five Year Out-Come in Two Cohorts of Patients with Early Rheumatoid Arthritis - A BARFOT Study.

Andersson ML, Forslind K, Hafström I.

Open Rheumatol J. 2015 Feb 3;9:8-15. doi: 10.2174/1874312901409010008. eCollection 2015.

6.

Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study.

Hafström I, Engvall IL, Rönnelid J, Boonen A, van der Heijde D, Svensson B; BARFOT study group.

BMJ Open. 2014 Jul 30;4(7):e005246. doi: 10.1136/bmjopen-2014-005246.

7.

Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial.

Ajeganova S, Svensson B, Hafström I; BARFOT Study Group.

BMJ Open. 2014 Apr 7;4(4):e004259. doi: 10.1136/bmjopen-2013-004259.

8.
9.

Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria.

Svensson B, Andersson ML, Bala SV, Forslind K, Hafström I; BARFOT study group.

BMJ Open. 2013 Sep 10;3(9):e003554. doi: 10.1136/bmjopen-2013-003554.

10.

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.

Andersson ML, Svensson B, Petersson IF, Hafström I, Albertsson K, Forslind K, Heinegård D, Saxne T.

BMC Musculoskelet Disord. 2013 Aug 2;14:229. doi: 10.1186/1471-2474-14-229.

11.

Does digital X-ray radiogrammetry have a role in identifying patients at increased risk for joint destruction in early rheumatoid arthritis?

Forslind K, Kälvesten J, Hafström I, Svensson B; BARFOT Study Group.

Arthritis Res Ther. 2012 Oct 15;14(5):R219. doi: 10.1186/ar4058.

12.

Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass--a cross sectional study.

Elkan AC, Håkansson N, Frostegård J, Hafström I.

BMC Musculoskelet Disord. 2011 Jan 14;12:13. doi: 10.1186/1471-2474-12-13.

13.
14.
15.

Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study.

Engvall IL, Svensson B, Tengstrand B, Brismar K, Hafström I; Better Anti-Rheumatic FarmacO Therapy Study Group.

Arthritis Res Ther. 2008;10(6):R128. doi: 10.1186/ar2542. Epub 2008 Nov 5.

16.

Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study.

Elkan AC, Sjöberg B, Kolsrud B, Ringertz B, Hafström I, Frostegård J.

Arthritis Res Ther. 2008;10(2):R34. doi: 10.1186/ar2388. Epub 2008 Mar 18.

17.

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

Hoes JN, Jacobs JW, Boers M, Boumpas D, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Esselens G, Guillevin L, Hafstrom I, Kirwan JR, Rovensky J, Russell A, Saag KG, Svensson B, Westhovens R, Zeidler H, Bijlsma JW.

Ann Rheum Dis. 2007 Dec;66(12):1560-7. Epub 2007 Jul 27.

18.

Sex: a major predictor of remission in early rheumatoid arthritis?

Forslind K, Hafström I, Ahlmén M, Svensson B; BARFOT Study Group.

Ann Rheum Dis. 2007 Jan;66(1):46-52. Epub 2006 Dec 7.

19.

Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B; BARFOT Study Group.

Ann Rheum Dis. 2004 Sep;63(9):1090-5.

20.

Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension.

Kvien TK, Zeidler HK, Hannonen P, Wollheim FA, Førre O, Hafström I, Kaltwasser JP, Leirisalo-Repo M, Manger B, Laasonen L, Prestele H, Kurki P.

Ann Rheum Dis. 2002 Jun;61(6):511-6.

Supplemental Content

Loading ...
Support Center